Navigation Links
Controversial Bird Flu Research to Resume
Date:1/23/2013

By Amanda Gardner
HealthDay Reporter

WEDNESDAY, Jan. 23 (HealthDay News) -- An international moratorium on bird flu research, instituted a year ago by researchers because of concerns that a mutated form of the virus could fall into the wrong hands, has been lifted.

In a letter published Jan. 23 in the journals Nature and Science, the 40 scientists who first agreed to halt any study of the H5N1 flu virus until safety guidelines were established now say that labs in countries that have since established such measures can resume their work.

However, the United States is not one of those countries, so any bird, or avian, flu research there is still on hold, the group said.

"It is believed that all of the conditions the moratorium was initially installed to meet have been met," Ron Fouchier, of the department of virology at Erasmus Medical Center in the Netherlands, said during a Wednesday news conference on the decision to lift the ban. "In our opinion, in those countries where research can be done safely, research should restart.

"The risk of this information in the manuscripts being misused by malicious people would be very, very small, if not negligible," Fouchier added.

Fouchier said his lab would not be restarting experiments immediately, but that "certainly it will not take months to start. Probably in the next few weeks."

Ending the moratorium is necessary for public health reasons, those scientists who signed the letter stated.

"We believe this research is important to pandemic preparedness," said Yoshihiro Kawaoka of the University of Wisconsin, Madison. "Our research to understand how avian viruses adapt to mammals will lead to better surveillance and vaccines... The greater risk is not doing research that could help us to be better equipped to deal with a pandemic."

The furor started in December 2011, when concerns that research into a genetically mutated for
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. U.S. Gives Green Light to Publish Controversial Bird Flu Research
2. Controversial vaccine trial should never have been run in India, researchers say
3. Supreme Court Backs Much of Controversial Health Reform Law
4. Stopping Controversial Asthma Drugs Could Have Downside: Study
5. Controversial Alternative Heart Treatment Shows Hint of Benefit
6. UCLA Brain Injury Research Center gets NCAA funding for research on sports concussions
7. NIH awards $20 million over 5 years to train next generation of global health researchers
8. Researchers develop a new cell and animal model of inflammatory breast cancer
9. Researchers uncover a viable way for colorectal cancer patients to overcome drug resistance
10. Sexually abused boys at risk for more unsafe sex: UBC research
11. Researchers Find Gene Mutations That May Be a Key to Autism
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Controversial Bird Flu Research to Resume 
(Date:6/19/2013)... New York, NY (PRWEB) June 19, 2013 ... Integrated Marketing Awards program is this Friday, June ... salutes the campaigns, ongoing programs and innovative people ... , For more information, visit http://www.minonline.com/ima . ... person or individual magazine title is eligible to ...
(Date:6/19/2013)... 2013 Today, Zane Benefits, Inc. published ... . Zane Benefits, which provides comprehensive and flexible alternatives ... in defined contribution and health reimbursement ... as part of the Affordable Care Act (ACA), health ... available through new state health insurance exchanges. , Most ...
(Date:6/19/2013)... KS (PRWEB) June 19, 2013 The ... is common with today’s computer software, it creates questions ... form of misconduct. As an already published case shows, ... photo manipulation. , The Journal of Parasitology ... manipulation in a 2004 article published in the ...
(Date:6/19/2013)... Philadelphia, Pa. (June 19, 2013) The results of ... issue of Neurosurgery , official journal of the ... is published by Lippincott Williams & Wilkins , ... One study indicates that continuous "machine learning" using artificial ... survival in patients with advanced brain cancers. Another study ...
(Date:6/19/2013)... (June 19, 2013) In early April, senior leaders ... in Hartford, Connecticut, to discuss one question: how can ... , The preliminary results of this discussion ... Shooter Events: The Hartford Consensus ," a concept paper ... Journal of Trauma and Acute Care Surgery ...
Breaking Medicine News(10 mins):Health News:Entry Deadline for min’s Integrated Marketing Awards Is This Friday, June 21 2Health News:Zane Benefits Publishes New Information on the Wisconsin Health Insurance Exchange 2Health News:Zane Benefits Publishes New Information on the Wisconsin Health Insurance Exchange 3Health News:Altered Photo in Journal Article Illustrates the Need for Manipulation Guidelines 2Health News:Neurosurgery publishes findings of 3 important studies in June issue 2Health News:Neurosurgery publishes findings of 3 important studies in June issue 3Health News:Hartford consensus aims to improve survival after mass shootings 2
... over the high prevalence of HIV/AIDS in Karnataka and hoping ... H.D. Kumaraswamy will spend Tuesday night in the hut of ... village in Bagalkot district, 600 km from the state capital ... at around 11 p.m. and spend the night in the ...
... in the January 22 issue of Archives of Internal Medicine, ... supplements appears to increase// the level of the essential mineral ... load in patients with HIV infection. ,Advances in ... expectancy, however, strict adherence to the therapy is required to ...
... that is first to identify - which malignant blood ... experimental drugs that unleash pent-up "cell suicide" factors to ... chronic lymphocytic leukemia, CLL, which is diagnosed in 10,000 ... new drug because the cancerous cells are strongly dependent ...
... a dozen people have taken ill and have been hospitalized ... and ‘ baseless’ by spokesman Xiong Yuanda of the Health ... no infectious ‘unknown’ disease, doing the rounds in the city, ... Health bureau has sought to dispel reports carried by a ...
... breast implants done for augmentation purposes or for firming up. ... have united to offer services in this field. ... rate compared to the so called cheaper clinics. They also ... are all a highly creditable force from the British Association ...
... out with a skin patch to treat Alzheimer’s. This ... promising//. According to these researchers, the skin patch is ... is said to occur when a protein called beta ... introduced through the skin attacks beta amyloid and breaks ...
Cached Medicine News:Health News:Karnataka Chief Minister to Spend Night With HIV Positive Family 2Health News:Selenium Supplements May Suppress HIV Viral Load 2Health News:New Test Predicts CLL’s Sensitivity to Experimental Drug 2Health News:New Test Predicts CLL’s Sensitivity to Experimental Drug 3
(Date:6/19/2013)... June 19, 2013 /PRNewswire-iReach/ -- In its ... specialty pharmaceutical company dedicated to advancing development ... and sustained release drug therapies in patient ... today announced the acquisition of Enzon Pharmaceutical,s ... and associated product pipeline. Acquisition of this ...
(Date:6/19/2013)... , June 19, 2013 Today MedeAnalytics, ... introduced the next-generation of its Employer Group ... health plans to provide their employer groups an ... factors, medical and prescription drug claims, network utilization, ... http://photos.prnewswire.com/prnh/20100621/SF23660LOGO ) "Employer Group ...
(Date:6/19/2013)... may seem like an odd pairing: an oral growth hormone-boosting ... two of the most talked about topics at ENDO 2013, ... that just convened in San Francisco . ... the top internal medicine experts in the world is very ... not only save lives, but help people feel and ...
Breaking Medicine Technology:Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 2Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 3Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 4MedeAnalytics Introduces Next-Generation Employer Group and Individual Business Analytics Solution 2"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 2"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 3"Miracle" Breast Cancer Drug and "Youth Hormone" Pill Steal Show at Prestigious Endocrine Society Conference 4
Nitinol Tipless Stone Basket...
1.5 Fr Nitinol Tipless Stone Basket...
Rapid latex agglutination test for presumptive identification of E. coli serogroup O157:H7 isolates. Colorimetric with red O157 latex and blue H7 latex....
For presumptive identification of Escherichia coli using enzyme technology. Tests: Indole, MUG...
Medicine Products: